Xtant Medical Holdings Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, Xtant Medical Holdings stock has a consensus rating of "Strong Buy" and an average price target of $1.23. The average 1-year stock price forecast is 173.88% higher than the current stock price, while the lowest is $1.00 (+122.67%) and the highest is $1.50 (+234.00%).

Price Target: $1.23 (+173.88%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$1.00	$1.23	$1.20	$1.50
Change	+122.67%	+173.88%	+167.20%	+234.00%

* Price targets were last updated on May 14, 2026.

Analyst Ratings

The average analyst rating for Xtant Medical Holdings stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '25	Nov '25	Dec '25	Mar '26	Apr '26	May '26
Strong Buy	2	2	2	2	2	2
Buy	0	0	0	0	0	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Chase Knickerbocker Craig-Hallum	Craig-Hallum	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 14, 2026
Jack Vander Aarde Maxim Group	Maxim Group	Buy Reiterates $0.95 → $1.5	Buy	Reiterates	$0.95 → $1.5	+234.00%	May 14, 2026
Ryan Zimmerman BTIG	BTIG	Buy Maintains $1.5 → $1	Buy	Maintains	$1.5 → $1	+122.67%	Apr 1, 2026

Financial Forecast

Revenue This Year

102.41M

from 133.93M

-23.54%

from 133.93M

Revenue Next Year

111.99M

from 102.41M

9.36%

from 102.41M

EPS This Year

-0.08

from 0.04

EPS Next Year

-0.01

from -0.08

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	55.26M	57.97M	91.30M	117.27M	133.93M	102.41M
Revenue Growth	3.61%	4.90%	57.50%	28.44%	14.21%	-23.54%
Gross Profit	32.49M	32.14M	55.47M	68.22M	84.27M	62.06M
Gross Margin	58.79%	55.44%	60.75%	58.17%	62.92%	60.60%
Operating Income	-3.25M	-6.76M	-10.16M	-12.07M	7.28M	-6.33M
Net Income	-4.85M	-8.49M	660.00K	-16.45M	4.97M	-6.78M
EPS	-	-	-	-	0.04	-0.08
Free Cash Flow	262.38K	-4.20M	-25.38M	-9.47M	6.50M	-4.40M
No. Analysts	-	-	-	-	-	3

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	103.1M
Avg	102.4M
Low	102.0M

Revenue Growth

Revenue Growth	2026	2027	2028
High	-23.0%
Avg	-23.5%
Low	-23.8%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.08
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-